反應(yīng)種屬: Human
Background: |
IGF-binding proteins prolong the half-life of IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs in cell culture. They alter the interaction of IGFs with their cell surface receptors (By similarity). May be a putative tumor suppressor protein. |
Applications: |
ELISA, IHC |
Name of antibody: |
IGFBPL1 |
Immunogen: |
Synthetic peptide of human IGFBPL1 |
Full name: |
insulin like growth factor binding protein like 1 |
Synonyms: |
IGFBPRP4; IGFBP-RP4; bA113O24.1 |
SwissProt: |
Q8WX77 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human thyroid cancer |
IHC Recommend dilution: |
50-300 |